{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31570745", "DateCompleted": {"Year": "2020", "Month": "11", "Day": "02"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "09", "Day": "30"}], "Language": ["eng"], "ELocationID": ["14003", "10.1038/s41598-019-50352-4"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "9", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Sep", "Day": "30"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Eugenol Reduces LDL Cholesterol and Hepatic Steatosis in Hypercholesterolemic Rats by Modulating TRPV1 Receptor.", "Pagination": {"StartPage": "14003", "MedlinePgn": "14003"}, "Abstract": {"AbstractText": ["Eugenol, a component of essential oils of medicinal and food plants, has a hypolipidemic effect in experimental animals although its mechanism of action is still unclear. This study aims to explore the mechanism of the hypolipidemic effect of eugenol in rats fed a high cholesterol and fat diet (HCFD). Eugenol significantly reduced total cholesterol (TC), low-density lipoproteins (LDL), atherogenic index (AI) but not high-density lipoproteins (HDL) or triglycerides (TG). Eugenol also decreased steatosis and hepatic inflammation in liver sections, decreased hepatomegaly, and the hepatic marker enzymes alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activity and increased the antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) activity in hypercholesterolemic rats. Eugenol did not inhibit hepatic 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase but caused down-regulation of transient receptor potential vanilloid (TRPV1) channels in the liver. Docking simulation using fast, rigid exhaustive docking (FRED) software indicated a tail-up/head-down interaction of eugenol with TRPV1 channel. Data indicate that eugenol does not inhibit HMG-CoA reductase but rather induces its action by interaction with TRPV1 channels."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, School of Science, The University of Jordan, Amman, 11942, Jordan."}], "LastName": "Harb", "ForeName": "Amani A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biopharmaceuticals and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, 11942, Jordan."}, {"Identifier": [], "Affiliation": "Hamdi Mango Center for Scientific research, The University of Jordan, Amman, 11942, Jordan."}], "LastName": "Bustanji", "ForeName": "Yasser K", "Initials": "YK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Gaza, Palestine."}], "LastName": "Almasri", "ForeName": "Ihab M", "Initials": "IM"}, {"Identifier": ["0000-0003-4532-276X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, School of Science, The University of Jordan, Amman, 11942, Jordan. shtaywy@yahoo.com."}], "LastName": "Abdalla", "ForeName": "Shtaywy S", "Initials": "SS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholesterol, LDL"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypolipidemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipoproteins, HDL"}, {"RegistryNumber": "0", "NameOfSubstance": "TRPV Cation Channels"}, {"RegistryNumber": "0", "NameOfSubstance": "TRPV1 receptor"}, {"RegistryNumber": "0", "NameOfSubstance": "Triglycerides"}, {"RegistryNumber": "3T8H1794QW", "NameOfSubstance": "Eugenol"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["blood"], "DescriptorName": "Cholesterol"}, {"QualifierName": ["blood", "metabolism"], "DescriptorName": "Cholesterol, LDL"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Eugenol"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Fatty Liver"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hypolipidemic Agents"}, {"QualifierName": ["blood"], "DescriptorName": "Lipoproteins, HDL"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "TRPV Cation Channels"}, {"QualifierName": ["blood"], "DescriptorName": "Triglycerides"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kaur G, Athar M, Alam MS. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Mol. Carcinogen. 2010;49:290\u2013301.", "ArticleIdList": ["20043298"]}, {"Citation": "Lahlou S, Interaminense LFL, Magalh\u00e3es PJC, Leal-Cardoso JH, Duarte GP. Cardiovascular effects of eugenol, a phenolic compound present in many plant essential oils, in normotensive rats. J. Cardiovasc. Pharmacol. 2004;43(2):250\u2013257. doi: 10.1097/00005344-200402000-00013.", "ArticleIdList": ["10.1097/00005344-200402000-00013", "14716213"]}, {"Citation": "Additives JFWECof. WHO technical report series 934: Evaluation of certain food additives. 49\u201354 (World Health Organization: Geneva, 2006).", "ArticleIdList": ["17069402"]}, {"Citation": "Nejad SM, \u00d6zgunes H, Basaran N. Pharmacological and toxicological properties of eugenol. Turk. J. Pharm. Sci. 2017;14(2):201\u2013206. doi: 10.4274/tjps.62207.", "ArticleIdList": ["10.4274/tjps.62207", "PMC7227856", "32454614"]}, {"Citation": "Jo HK, Kim GW, Jeong KJ, Kim DY, Chung SH. Eugenol ameliorates hepatic steatosis and fibrosis by down-regulating SREBP1 gene expression via AMPK-mTOR-p70S6K signaling pathway. Biol. Pharm. Bull. 2014;37:1341\u20131351. doi: 10.1248/bpb.b14-00281.", "ArticleIdList": ["10.1248/bpb.b14-00281", "25087956"]}, {"Citation": "Yogalakshmi B, Viswanathan P, Anuradha CV. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology. 2010;268:204\u2013212. doi: 10.1016/j.tox.2009.12.018.", "ArticleIdList": ["10.1016/j.tox.2009.12.018", "20036707"]}, {"Citation": "Khunkitti W, Veerapan P. Hahnvajanawong, C. In vitro bioactivities of clove buds oil (Eugenia caryophyllata) and its effect on dermal fibroblast. Int. J. Pharm. Pharm. Sci. 2012;4:556\u2013560."}, {"Citation": "Al-Trad B, Alkhateeb H, Alsmadi W, Al-Zoubi M. Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat-diet/streptozotocin-induced diabetic rat. LifeSciences. 2019;216:183\u2013188. doi: 10.1016/j.lfs.2018.11.034.", "ArticleIdList": ["10.1016/j.lfs.2018.11.034", "30448265"]}, {"Citation": "Damiani CEN, Rossoni LV, Vassallo D. Vasorelaxant effects of eugenol on rat thoracic aorta. Vasc. Pharmacol. 2003;40(1):59\u201366. doi: 10.1016/S1537-1891(02)00311-7.", "ArticleIdList": ["10.1016/S1537-1891(02)00311-7", "12646411"]}, {"Citation": "Srinivasan S, et al. Ameliorating effect of eugenol on hyperglycemia by attenuating the key enzymes of glucose metabolism in streptozotocin-induced diabetic rats. Mol. Cell Biochem. 2014;385:159\u2013168. doi: 10.1007/s11010-013-1824-2.", "ArticleIdList": ["10.1007/s11010-013-1824-2", "24078031"]}, {"Citation": "Suanarunsawat T, Ayutthaya WDN, Songsak T, Thirawarapan S, Poungshompoo S. Antioxidant activity and lipid-lowering effect of essential oils extracted from Ocimum sanctum L. leaves in rats fed with a high cholesterol diet. J. Clin. Biochem. Nutr. 2010;46:52\u201359. doi: 10.3164/jcbn.09-52.", "ArticleIdList": ["10.3164/jcbn.09-52", "PMC2803133", "20104265"]}, {"Citation": "Karimi I, et al. Anti-hyperlipidaemic effects of an essential oil of Melissa officinalis L. in cholesterol-fed rabbits. J. Applied Bio. Sci. 2010;4:17\u201322."}, {"Citation": "Balasasirekha R, Lakshmi UK. Effect of cloves and turmeric on hyperlipidemics. J. Hum. Ecol. 2012;37:125\u2013132. doi: 10.1080/09709274.2012.11906456.", "ArticleIdList": ["10.1080/09709274.2012.11906456"]}, {"Citation": "Venkadeswaran K, et al. Antihypercholesterolemic and antioxidative potential of an extract of the plant, Piper betle, and its active constituent, eugenol, in triton WR-1339-induced hypercholesterolemia in experimental rats. Evid. Based Complement. Alternat. Med. 2014;2014:1\u201311. doi: 10.1155/2014/478973.", "ArticleIdList": ["10.1155/2014/478973", "PMC3913032", "24523820"]}, {"Citation": "Al-Okbi SY, Mohamed DA, Hamed TE, Edris AE. Protective effect of clove oil and eugenol microemulsions on fatty liver and dyslipidemia as components of metabolic syndrome. J. Med. Food. 2014;17(7):764\u2013771. doi: 10.1089/jmf.2013.0033.", "ArticleIdList": ["10.1089/jmf.2013.0033", "24611461"]}, {"Citation": "Elbahy DA, Madkour HI, Abdel-Raheem MH. Evaluation of antihyperlipidemic activity of eugenol in triton induced hyperlipidemia in rats. Int. J. Res. Stud. Biosci. 2015;3(10):19\u201326."}, {"Citation": "Karam I, et al. Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia. BMC Vet. Res. 2015;11:217. doi: 10.1186/s12917-015-0523-5.", "ArticleIdList": ["10.1186/s12917-015-0523-5", "PMC4546030", "26289078"]}, {"Citation": "Yang BH, et al. Activation of vanilloid receptor 1 (VR1) by eugenol. J. Dent. Res. 2003;82:781\u2013785. doi: 10.1177/154405910308201004.", "ArticleIdList": ["10.1177/154405910308201004", "14514756"]}, {"Citation": "Bishnoi M, Kondepudi KK, Baboota RK, Dubey R, Boparai RK. Role of transient receptor potential channels in adipocyte biology. Expert Rev. Endocrinol. Metab. 2013;8:173\u2013182. doi: 10.1586/eem.13.4.", "ArticleIdList": ["10.1586/eem.13.4", "30736177"]}, {"Citation": "Caterina MJ, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816\u2013824. doi: 10.1038/39807.", "ArticleIdList": ["10.1038/39807", "9349813"]}, {"Citation": "Wang P, Liu D, Zhu Z. Transient receptor potential vanilloid type-1 channel in cardiometabolic protection. J. Korean Soc. Hypertens. 2011;17:37\u201347. doi: 10.5646/jksh.2011.17.2.37.", "ArticleIdList": ["10.5646/jksh.2011.17.2.37"]}, {"Citation": "Wang GY, Wang LL, Xu B, Zhang JB, Jiang JF. Effects of moxibustion temperature on blood cholesterol level in a mice model of acute hyperlipidemia: Role of TRPV1. Evid. Based Complement. Alternat. Med. 2013;2013:1\u20137.", "ArticleIdList": ["PMC3713370", "23935685"]}, {"Citation": "Yuan G, Erhu C, David J, Yifan C. TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action. Nature. 2016;534:347\u2013351. doi: 10.1038/nature17964.", "ArticleIdList": ["10.1038/nature17964", "PMC4911334", "27281200"]}, {"Citation": "Harb AA, Bustanji YK, Abdalla SS. Hypocholesterolemic effect of \u03b2-caryophyllene in rats fed cholesterol and fat enriched diet. J. Clin. Biochem. Nutr. 2018;62(3):230\u2013237. doi: 10.3164/jcbn.17-3.", "ArticleIdList": ["10.3164/jcbn.17-3", "PMC5990408", "29892161"]}, {"Citation": "Sinnott B, Syed I, Sevrukov A, Barengolts E. Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif. Tissue Int. 2006;78:195\u2013202. doi: 10.1007/s00223-005-0244-z.", "ArticleIdList": ["10.1007/s00223-005-0244-z", "16604285"]}, {"Citation": "Rao AV, Ramakrishnan S. Indirect assessment of hydroxymethylglutaryl-CoA reductase (NADPH) activity in liver tissue. Clin. Chem. 1975;21:1523\u20131525.", "ArticleIdList": ["1157326"]}, {"Citation": "Kawasaki T, et al. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J. Nutr. 2009;139:2067\u20132071. doi: 10.3945/jn.109.105858.", "ArticleIdList": ["10.3945/jn.109.105858", "19776184"]}, {"Citation": "Mennesson N, et al. Liver steatosis quantification using magnetic resonance imaging: A prospective comparative study with liver biopsy. J. Comput. Assist. Tomogr. 2009;33:672\u2013677. doi: 10.1097/RCT.0b013e318199d883.", "ArticleIdList": ["10.1097/RCT.0b013e318199d883", "19820490"]}, {"Citation": "Jafari SMS, Hunger RE. IHC Optical Density Score: A New Practical Method for Quantitative Immunohistochemistry Image Analysis. Appl. Immunohistochem. Mol. Morphol. 2017;25(1):e12\u2013e13.", "ArticleIdList": ["27093452"]}, {"Citation": "Williamson, E. M., Okpako, D. T. & Evans, F. J. Selection, preparation and pharmacological evaluation of plant materials. In: Williamson EM, editor. Pharmacological methods in phytotherapy research, Chichester: John Wiley, 184\u2013186 (1996)."}, {"Citation": "Motter AL, Ahern GP. TRPV1-null mice are protected from diet-induced obesity. FEBS letters. 2008;582(15):2257\u20132262. doi: 10.1016/j.febslet.2008.05.021.", "ArticleIdList": ["10.1016/j.febslet.2008.05.021", "PMC2486372", "18503767"]}, {"Citation": "Zhao JF, et al. Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-\u03b1-induced inflammation in macrophages: role of liver X receptor \u03b1. Mediat. Inflamm. 2013;2013:925171.", "ArticleIdList": ["PMC3710635", "23878415"]}, {"Citation": "Sanz-Salvador L, Andr\u00e9s-Borderia A, Ferrer-Montiel A, Planells-Cases R. Agonist- and Ca2+-dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation. J. Biol. Chem. 2012;287(23):19462\u201371. doi: 10.1074/jbc.M111.289751.", "ArticleIdList": ["10.1074/jbc.M111.289751", "PMC3365984", "22493457"]}, {"Citation": "Su KH, et al. The essential role of transient receptor potential vanilloid 1 in simvastatin\u2010induced activation of endothelial nitric oxide synthase and angiogenesis. Acta. Physiolo. 2014;212(3):191\u2013204. doi: 10.1111/apha.12378.", "ArticleIdList": ["10.1111/apha.12378", "25183024"]}, {"Citation": "Carnevale V, Rohacs T. TRPV1: A Target for Rational Drug Design. Pharmaceuticals. 2016;9(3):E52. doi: 10.3390/ph9030052.", "ArticleIdList": ["10.3390/ph9030052", "PMC5039505", "27563913"]}, {"Citation": "Saha S, et al. Preferential selection of arginine at the lipid-water-interface TRPV1 during vertebrate evolution of correlates with its snorkeling behaviour and cholesterol interaction. Sci. Reports. 2017;7:16808. doi: 10.1038/s41598-017-16780-w.", "ArticleIdList": ["10.1038/s41598-017-16780-w", "PMC5711878", "29196683"]}, {"Citation": "Yang F, et al. Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel. Nat. Chem. Biol. 2015;11:518\u2013524. doi: 10.1038/nchembio.1835.", "ArticleIdList": ["10.1038/nchembio.1835", "PMC4472570", "26053297"]}, {"Citation": "Darre L, Domene C. Binding of capsaicin to the TRPV1 ion channel. Mol. Pharm. 2015;12:4454\u20134465. doi: 10.1021/acs.molpharmaceut.5b00641.", "ArticleIdList": ["10.1021/acs.molpharmaceut.5b00641", "26502196"]}, {"Citation": "Ji G, Zhao X, Leng L, Liu P, Jiang Z. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats. Lipids Health Dis. 2011;10:23\u201332. doi: 10.1186/1476-511X-10-23.", "ArticleIdList": ["10.1186/1476-511X-10-23", "PMC3040155", "21269482"]}, {"Citation": "Jornayvaz FR, et al. A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. Am. J. Physiol. Endocrinol. Metab. 2010;299(5):E808\u2013E815. doi: 10.1152/ajpendo.00361.2010.", "ArticleIdList": ["10.1152/ajpendo.00361.2010", "PMC2980360", "20807839"]}, {"Citation": "Gao S, Wang Y, Zhang P, Dong Y, Li B. Subacute oral exposure to dibromoacetic acid induced immunotoxicity and apoptosis in the spleen and thymus of the mice. Toxicol. Sci. 2008;105:331\u2013341. doi: 10.1093/toxsci/kfn139.", "ArticleIdList": ["10.1093/toxsci/kfn139", "18628252"]}, {"Citation": "Goldman M. Cancer risk of low-level exposure. Science. 1996;271(5257):1821\u20131822. doi: 10.1126/science.271.5257.1821.", "ArticleIdList": ["10.1126/science.271.5257.1821", "8596947"]}]}], "History": [{"Year": "2019", "Month": "6", "Day": "12"}, {"Year": "2019", "Month": "9", "Day": "11"}, {"Year": "2019", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["31570745", "PMC6768860", "10.1038/s41598-019-50352-4", "10.1038/s41598-019-50352-4"]}}]}